Deutsche Bank
AQST icon

Deutsche Bank’s Aquestive Therapeutics AQST Stock Holding History

Deutsche Bank’s Portfolio AQST Stock Details AQST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$441K Buy
106,028
+18,580
+21% +$78.2K ﹤0.01% 2839
2026
Q1 		$363K Buy
87,448
+4,019
+5% +$16.3K ﹤0.01% 2737
2025
Q4 		$539K Buy
83,429
+8,625
+12% +$53.7K ﹤0.01% 2523
2025
Q3 		$418K Buy
74,804
+10,481
+16% +$45.3K ﹤0.01% 2649
2025
Q2 		$213K Buy
64,323
+9,723
+18% +$27.9K ﹤0.01% 2933
2025
Q1 		$158K Sell
54,600
-7,389
-12% -$22.4K ﹤0.01% 3056
2024
Q4 		$221K Buy
61,989
+24,170
+64% +$111K ﹤0.01% 3056
2024
Q3 		$188K Buy
+37,819
New +$147K ﹤0.01% 2953
2021
Q4 		– Sell
-21
Closed – – 4241
2021
Q3 		$0 Sell
21
-1,377
-98% -$5.4K ﹤0.01% 4394
2021
Q2 		$6K Sell
1,398
-12,734
-90% -$50.9K ﹤0.01% 4492
2021
Q1 		$73K Sell
14,132
-4,785
-25% -$25.5K ﹤0.01% 4126
2020
Q4 		$101K Sell
18,917
-91,360
-83% -$548K ﹤0.01% 3843
2020
Q3 		$535K Buy
110,277
+99,908
+964% +$653K ﹤0.01% 2599
2020
Q2 		$50K Buy
+10,369
New +$47.7K ﹤0.01% 3819
2019
Q3 		– Sell
-3,957
Closed -$15K – 4862
2019
Q2 		$15K Sell
3,957
-8,434
-68% -$43.2K ﹤0.01% 4872
2019
Q1 		$84K Buy
12,391
+7,914
+177% +$55.4K ﹤0.01% 4363
2018
Q4 		$27K Sell
4,477
-7,375
-62% -$93.1K ﹤0.01% 4664
2018
Q3 		$207K Buy
+11,852
New +$195K ﹤0.01% 4222

Other funds holding AQST

BCM
Bratton Capital Management Fort Worth, Texas $40.8M AUM 25.68% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.22B AUM 242.83% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
SCM
Sio Capital Management New York $604M AUM 96.57% 1-Year Est. Return

Deutsche Bank's AQST Position: Q2 2026 in Review

Deutsche Bank increased its Aquestive Therapeutics (AQST) stake by 21% in Q2 2026, buying an estimated $78.2K and bringing the position to 106,028 shares worth $441K. The position accounts for ﹤0.01% of the portfolio, ranked #2839.

Deutsche Bank first reported a position in AQST in Q3 2018 and has held it in 18 quarters since. The position peaked at $539K in Q4 2025. 184 funds tracked by Wall St. Rank hold AQST as of Q2 2026.

  • Deutsche Bank held 106,028 shares of Aquestive Therapeutics worth $441K as of Q2 2026.
  • Deutsche Bank bought 18,580 Aquestive Therapeutics shares in Q2 2026, an estimated $78.2K.
  • Aquestive Therapeutics made up ﹤0.01% of Deutsche Bank's portfolio in Q2 2026, its #2839 holding.
  • Deutsche Bank first reported a position in Aquestive Therapeutics in Q3 2018 and has held it in 18 quarters since.
  • Deutsche Bank's Aquestive Therapeutics position peaked at $539K in Q4 2025.
  • 184 funds tracked by Wall St. Rank held Aquestive Therapeutics as of Q2 2026.

Based on Deutsche Bank's 13F filing for Q2 2026, filed 7 Aug 2026.